2020
DOI: 10.1016/j.jaip.2020.07.007
|View full text |Cite
|
Sign up to set email alerts
|

Penicillin allergy labels drive perioperative prophylactic antibiotic selection in orthopedic procedures

Abstract: This is a PDF file of an article that has undergone enhancements after acceptance, such as the addition of a cover page and metadata, and formatting for readability, but it is not yet the definitive version of record. This version will undergo additional copyediting, typesetting and review before it is published in its final form, but we are providing this version to give early visibility of the article. Please note that, during the production process, errors may be discovered which could affect the content, a… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
6
0

Year Published

2021
2021
2023
2023

Publication Types

Select...
9

Relationship

2
7

Authors

Journals

citations
Cited by 11 publications
(6 citation statements)
references
References 9 publications
0
6
0
Order By: Relevance
“…Another area of risk stratification is utilization of cefazolin for preoperative prophylaxis for patients with PALs. Preoperative antibiotic selection is negatively impacted by unevaluated PALs and can increase the risk of surgical site infections [29,30]. It has been demonstrated through implementation of education and changing hospital procedures for selection of surgical prophylactic antibiotics, that even those with a history of a potential IgE mediated reaction to penicillin receive and tolerate cefazolin (whose R1 side chain is not shared by any other penicillin or cephalosporin in the United States) [31][32][33][34][35][36][37].…”
Section: Updates In Risk-stratified Managementmentioning
confidence: 99%
“…Another area of risk stratification is utilization of cefazolin for preoperative prophylaxis for patients with PALs. Preoperative antibiotic selection is negatively impacted by unevaluated PALs and can increase the risk of surgical site infections [29,30]. It has been demonstrated through implementation of education and changing hospital procedures for selection of surgical prophylactic antibiotics, that even those with a history of a potential IgE mediated reaction to penicillin receive and tolerate cefazolin (whose R1 side chain is not shared by any other penicillin or cephalosporin in the United States) [31][32][33][34][35][36][37].…”
Section: Updates In Risk-stratified Managementmentioning
confidence: 99%
“…Due to their relatively benign risk profile and broad-spectrum antimicrobial activity, recent CPGs have endorsed the use of either first or second-generation cephalosporins as the primary method of antibiotic prophylaxis in this setting [ 25 ]. Although surgeons have traditionally been discouraged from administering cephalosporins in patients with self-reported penicillin allergies, we now know that cross-reactivity between cephalosporins and penicillin is uncommon [ 26 ]. Furthermore, in the absence of a documented history of an anaphylactic reaction to penicillin, self-reported penicillin allergies are often inconsequential, making cephalosporins a safe and practical option in these patients [ 27 ].…”
Section: Introductionmentioning
confidence: 99%
“…3 In orthopaedic surgery, a PAL is the primary driver for choosing an alternative perioperative antibiotic, with clindamycin being used most frequently (Odds Ratio [OR] 34.6, 95% Confidence Interval [CI] 29.9 to 30.1, P , 0.005). 4 The use of these second-line antibiotics leads to increased healthcare-associated infections, including a 23% increased odds of Clostridium difficile, a 14% increased odds of methicillin-resistant Staphylococcus aureus, and a 30% increased odds of vancomycin-resistant Enterococcus. [5][6][7] In another multisite, prospective cohort study, beta-lactam allergic patients who received a nonbeta-lactam antibiotic as opposed to a beta-lactam antibiotic had markedly more adverse events reported in the form of hospital readmissions for the same infection, acute kidney injury, C difficile, or other drug-related events (OR 3.2, 95% CI 1.28 to 7.89).…”
mentioning
confidence: 99%